Body mass index and fasting insulin predict survival and EGFR–TKI benefit in Stage IV lung adenocarcinoma - Poll - MDSpire

Body mass index and fasting insulin predict survival and EGFR–TKI benefit in Stage IV lung adenocarcinoma

  • By

  • Huiru Guo

  • Lingshuang Liu

  • Jan P. A. Baak

  • June 25, 2026

  • 0 min

Share

Original Source(s)

Body mass index and fasting insulin predict survival and EGFR–TKI benefit in Stage IV lung adenocarcinoma

  • by Huiru Guo, Lingshuang Liu, Jan P. A. Baak

  • June 25, 2026

Related Content

Exposure to aircraft noise exacerbates cardiovascular and oxidative damage in three mouse models of diabetes

Chronotropic incompetency during stress echocardiography: a new paradigm for mortality and cardiac event prediction?

Temple Syndrome: Comprehensive Clinical Study in Genetically Confirmed 60 Japanese Patients